In 2024, I warned that the Biopharmaceutical Complex was preparing for the large-scale deployment of replicon (self-amplifying) mRNA injections. At that time, there were at least 33 candidates in development.
Below is the timeline of primary samRNA developments since 2022:
- APR 2025 - U.S. FDA fast tracks Gates & BARDA- funded self-amplifying mRNA bird flu injection (Arcturus Therapeutics - ARCT - 2304)
- FEB 2025 - EU approves COVID-19 samRNA injection (Arcturus Therapeutics - ARCT-154)
- NOV 2024 - U.S. FDA authorizes trial for H5N1 bird flu samRNA injection (Arcturus Therapeutics - ARCT - 2304)
- JUN 2024 - USDA approves Merck's experimental saRNA shot for dogs and cats (Nobivac NXT)
- NOV 2023 - Japan fully approves COVID-19 samRNA injection (Arcturus Therapeutics - ARCT-154)
- JUNE 2022 - India authorizes very first COVID-19 samRNA injection for human use (Gennova Biopharmaceuticals - GEMCOVAC-19)













Comment: Bioweapons galore, because they hate humanity that much.